Biocon share price has rallied over 20% in one month and has gained 17% in three months. The stock has surged 28% in six ...
Siddharth Mittal resigned as CEO and MD of Biocon on Friday.
The Bengaluru-based drugmaker has approvals for biosimilar versions of Insulin Glargine, Insulin Aspart and Human Insulin.